vs
NEPHROS INC（NEPH）与High Roller Technologies, Inc.（ROLR）财务数据对比。点击上方公司名可切换其他公司
High Roller Technologies, Inc.的季度营收约是NEPHROS INC的1.3倍（$6.3M vs $4.7M），High Roller Technologies, Inc.净利率更高（58.4% vs 1.3%，领先57.1%），NEPHROS INC同比增速更快（22.2% vs -16.4%）
Nephros Inc是一家医疗科技企业，主要研发和销售高性能净水系统、感染防控产品及肾脏护理解决方案，产品主要供给北美地区的医院、透析诊所以及长期护理机构，用于降低水传播病原体风险，提升患者诊疗效果。
该企业主营游乐设施业务，凭借气动驱动技术打造各类游乐设备，专业从事过山车设计研发，在游乐设施设计制造领域拥有相关技术积累与行业经验。
NEPH vs ROLR — 直观对比
营收规模更大
ROLR
是对方的1.3倍
$4.7M
营收增速更快
NEPH
高出38.6%
-16.4%
净利率更高
ROLR
高出57.1%
1.3%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.7M | $6.3M |
| 净利润 | $62.0K | $3.7M |
| 毛利率 | 58.4% | — |
| 营业利润率 | 0.4% | 1.3% |
| 净利率 | 1.3% | 58.4% |
| 营收同比 | 22.2% | -16.4% |
| 净利润同比 | -82.2% | 831.9% |
| 每股收益（稀释后） | $0.01 | $0.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEPHROLR
| Q4 25 | $4.7M | — | ||
| Q3 25 | $4.8M | $6.3M | ||
| Q2 25 | $4.4M | $6.9M | ||
| Q1 25 | $4.9M | $6.8M | ||
| Q4 24 | $3.9M | — | ||
| Q3 24 | $3.5M | $7.5M | ||
| Q2 24 | $3.3M | — | ||
| Q1 24 | $3.5M | — |
净利润NEPHROLR
| Q4 25 | $62.0K | — | ||
| Q3 25 | $337.0K | $3.7M | ||
| Q2 25 | $237.0K | $-592.0K | ||
| Q1 25 | $558.0K | $-3.3M | ||
| Q4 24 | $349.0K | — | ||
| Q3 24 | $183.0K | $-501.0K | ||
| Q2 24 | $-289.0K | — | ||
| Q1 24 | $-169.0K | — |
毛利率NEPHROLR
| Q4 25 | 58.4% | — | ||
| Q3 25 | 61.2% | — | ||
| Q2 25 | 63.2% | — | ||
| Q1 25 | 64.7% | — | ||
| Q4 24 | 64.0% | — | ||
| Q3 24 | 61.1% | — | ||
| Q2 24 | 58.8% | — | ||
| Q1 24 | 62.1% | — |
营业利润率NEPHROLR
| Q4 25 | 0.4% | — | ||
| Q3 25 | 6.6% | 1.3% | ||
| Q2 25 | 5.6% | -7.2% | ||
| Q1 25 | 11.6% | -47.4% | ||
| Q4 24 | 8.2% | — | ||
| Q3 24 | 5.9% | -6.3% | ||
| Q2 24 | -9.7% | — | ||
| Q1 24 | -5.7% | — |
净利率NEPHROLR
| Q4 25 | 1.3% | — | ||
| Q3 25 | 7.1% | 58.4% | ||
| Q2 25 | 5.4% | -8.5% | ||
| Q1 25 | 11.4% | -48.4% | ||
| Q4 24 | 9.0% | — | ||
| Q3 24 | 5.2% | -6.7% | ||
| Q2 24 | -8.9% | — | ||
| Q1 24 | -4.8% | — |
每股收益（稀释后）NEPHROLR
| Q4 25 | $0.01 | — | ||
| Q3 25 | $0.03 | $0.39 | ||
| Q2 25 | $0.02 | $-0.07 | ||
| Q1 25 | $0.05 | $-0.39 | ||
| Q4 24 | $0.04 | — | ||
| Q3 24 | $0.02 | $-0.07 | ||
| Q2 24 | $-0.03 | — | ||
| Q1 24 | $-0.02 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.4M | $2.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $10.2M | $6.6M |
| 总资产 | $13.6M | $16.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NEPHROLR
| Q4 25 | $5.4M | — | ||
| Q3 25 | $5.2M | $2.7M | ||
| Q2 25 | $5.1M | $2.7M | ||
| Q1 25 | $4.1M | $3.5M | ||
| Q4 24 | $3.8M | — | ||
| Q3 24 | $2.5M | $1.3M | ||
| Q2 24 | $3.1M | — | ||
| Q1 24 | $3.6M | — |
股东权益NEPHROLR
| Q4 25 | $10.2M | — | ||
| Q3 25 | $10.0M | $6.6M | ||
| Q2 25 | $9.6M | $2.6M | ||
| Q1 25 | $9.3M | $2.8M | ||
| Q4 24 | $8.6M | — | ||
| Q3 24 | $8.2M | $-779.0K | ||
| Q2 24 | $7.9M | — | ||
| Q1 24 | $8.2M | — |
总资产NEPHROLR
| Q4 25 | $13.6M | — | ||
| Q3 25 | $13.2M | $16.0M | ||
| Q2 25 | $12.2M | $12.3M | ||
| Q1 25 | $11.8M | $12.8M | ||
| Q4 24 | $11.2M | — | ||
| Q3 24 | $10.4M | $12.9M | ||
| Q2 24 | $11.1M | — | ||
| Q1 24 | $11.4M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $230.0K | $-78.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-90.0K |
| 自由现金流率自由现金流/营收 | — | -1.4% |
| 资本支出强度资本支出/营收 | — | 0.2% |
| 现金转化率经营现金流/净利润 | 3.71× | -0.02× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NEPHROLR
| Q4 25 | $230.0K | — | ||
| Q3 25 | $99.0K | $-78.0K | ||
| Q2 25 | $994.0K | $-840.0K | ||
| Q1 25 | $322.0K | $-3.6M | ||
| Q4 24 | $1.3M | — | ||
| Q3 24 | $-623.0K | — | ||
| Q2 24 | $-501.0K | — | ||
| Q1 24 | $-672.0K | — |
自由现金流NEPHROLR
| Q4 25 | — | — | ||
| Q3 25 | — | $-90.0K | ||
| Q2 25 | — | $-845.0K | ||
| Q1 25 | — | $-3.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率NEPHROLR
| Q4 25 | — | — | ||
| Q3 25 | — | -1.4% | ||
| Q2 25 | — | -12.2% | ||
| Q1 25 | — | -53.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度NEPHROLR
| Q4 25 | — | — | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率NEPHROLR
| Q4 25 | 3.71× | — | ||
| Q3 25 | 0.29× | -0.02× | ||
| Q2 25 | 4.19× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 3.74× | — | ||
| Q3 24 | -3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NEPH
| Products | $4.6M | 98% |
| Other | $108.0K | 2% |
ROLR
| Net Gaming Revenue | $4.9M | 77% |
| Net Revenue Noncore Services | $1.4M | 23% |
